Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Jan 3, 2017
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-03+55,000→ 55,000 totalExercise: $12.88Exp: 2027-01-03→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 3, 2017.